Filing search / Context Therapeutics Inc. / "Environment"

424B3

CNTX Context Therapeutics Inc.

31 May 24

Prospectus supplement

4:06pm

in the forward-looking statements. Moreover, we operate in an evolving environment. New risk factors and uncertainties may emerge from time to time

8-K

EX-10.1

CNTX Context Therapeutics Inc.

2 May 24

Context Therapeutics Announces $100 Million Private Placement

7:37am

) are in compliance with all federal, state, local and foreign laws relating to pollution or protection of human health or the environment (including ambient air … of chemicals, pollutants, contaminants, or toxic or hazardous substances or wastes (collectively, “Hazardous Materials”) into the environment

424B3

k73fugo

14 Nov 22

Prospectus supplement

4:12pm

POS AM

ohc 5m8yq

9 Nov 22

Prospectus update (post-effective amendment)

4:36pm

S-3

m0odoosg qjsf

9 Nov 22

Shelf registration

4:35pm

424B3

ulz7a6swho3gat4 gsh

12 Apr 22

Prospectus supplement

4:14pm

POS AM

bhlbpfhvessldkw5

4 Apr 22

Prospectus update (post-effective amendment)

5:08pm

DEF 14A

phc cimv6bvw0

4 Apr 22

Definitive proxy

4:10pm

10-K

6evvr9hq0m10f29wa

23 Mar 22

Annual report

4:17pm

10-Q

EX-10.3

v0oeixxyf

2 Dec 21

Quarterly report

4:06pm